InventisBio Co

InventisBio Co Minority Interest

Minority Interest (Non-Controlling Interest) of InventisBio Co (688382.SS) as of Oct 18, 2026.

Minority Interest

-CNY

Last updated:

Minority Interest (Non-Controlling Interest) of InventisBio Co is 2026 - CNY. Minority Interest (Non-Controlling Interest) of InventisBio Co was 2025 - CNY. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

InventisBio Co Stock analysis

What does InventisBio Co do? InventisBio Co Ltd, headquartered in Shanghai, China, operates in the Health Care sector within the Biotechnology industry. The company employs 222 full-time staff and completed its IPO on July 25, 2022. InventisBio focuses on drug research and development for major diseases including tumors and metabolic conditions. Its core products under clinical development include D-0120, D-0502, D-1553, and BPI-D0316, targeting oncology and metabolic disease areas. InventisBio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about InventisBio Co stock

On Eulerpool you can find the complete historical development of Minority Interest (Non-Controlling Interest) InventisBio Co since 2006 – with annual values, charts, and detailed analysis.

Minority interest represents the portion of subsidiaries not owned by the parent company. It reflects third-party ownership stakes in consolidated entities.

Minority Interest (Non-Controlling Interest)'s CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Minority Interest (Non-Controlling Interest)'s InventisBio Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — InventisBio Co

All Key Metrics — InventisBio Co